Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Cave

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|August 20, 2025
Prediction of silica nanoparticle biodistribution using a calibrated physiologically based model: Unbound fraction and elimination rate constants for the kidneys and phagocytosis identified as major determinantsMadison Parrot, Joseph Cave, Maria J Pelaez, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
A Minimal PBPK Model Describes the Differential Disposition of Silica Nanoparticles In VivoMadison Parrot, Joseph Cave, Maria J Pelaez, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 12, 2023
Mechanistic modeling of anti-microRNA-155 therapy combinations in lung cancerJoseph Cave, Vrushaly Shinglot, Joseph D Butner, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Image-Guided Targeting of Mitochondrial Metabolism Sensitizes Pediatric Malignant Rhabdoid Tumors to Low Dose RadiotherapyWenxi Xia, Matthew Goff, Carmine Schiavone, et al.
Research Square|March 4, 2025
Rational Design of Safer Inorganic Nanoparticles via Mechanistic Modeling-informed Machine LearningJoseph Cave, Anne Christiono, Carmine Schiavone, et al.
ACS Nano|June 3, 2025
Rational Design of Safer Inorganic Nanoparticles via Mechanistic Modeling-Informed Machine LearningJoseph Cave, Anne Christiono, Carmine Schiavone, et al.
Molecular Cancer|August 2, 2024
Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancerPrashant Dogra, Vrushaly Shinglot, Javier Ruiz-Ramírez, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2024
Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancerPrashant Dogra, Vrushaly Shinglot, Javier Ruiz-Ramírez, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Rational Design of Immunogenic Nanoparticles as a Platform for Enhanced Ovarian Cancer Immunotherapy in MiceLien Tang, Ben Marwedel, Caleb Dang, et al.
International Journal of Pharmaceutics|October 5, 2025
Rational design of immunogenic nanoparticles as a platform to reduce ovarian tumor burden in miceLien Tang, Ben Marwedel, Caleb Dang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
International Journal of Clinical Pharmacology and Therapeutics|August 20, 2025
Prediction of silica nanoparticle biodistribution using a calibrated physiologically based model: Unbound fraction and elimination rate constants for the kidneys and phagocytosis identified as major determinantsMadison Parrot, Joseph Cave, Maria J Pelaez, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
A Minimal PBPK Model Describes the Differential Disposition of Silica Nanoparticles In VivoMadison Parrot, Joseph Cave, Maria J Pelaez, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 12, 2023
Mechanistic modeling of anti-microRNA-155 therapy combinations in lung cancerJoseph Cave, Vrushaly Shinglot, Joseph D Butner, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Image-Guided Targeting of Mitochondrial Metabolism Sensitizes Pediatric Malignant Rhabdoid Tumors to Low Dose RadiotherapyWenxi Xia, Matthew Goff, Carmine Schiavone, et al.
Research Square|March 4, 2025
Rational Design of Safer Inorganic Nanoparticles via Mechanistic Modeling-informed Machine LearningJoseph Cave, Anne Christiono, Carmine Schiavone, et al.
ACS Nano|June 3, 2025
Rational Design of Safer Inorganic Nanoparticles via Mechanistic Modeling-Informed Machine LearningJoseph Cave, Anne Christiono, Carmine Schiavone, et al.
Molecular Cancer|August 2, 2024
Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancerPrashant Dogra, Vrushaly Shinglot, Javier Ruiz-Ramírez, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2024
Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancerPrashant Dogra, Vrushaly Shinglot, Javier Ruiz-Ramírez, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Rational Design of Immunogenic Nanoparticles as a Platform for Enhanced Ovarian Cancer Immunotherapy in MiceLien Tang, Ben Marwedel, Caleb Dang, et al.
International Journal of Pharmaceutics|October 5, 2025
Rational design of immunogenic nanoparticles as a platform to reduce ovarian tumor burden in miceLien Tang, Ben Marwedel, Caleb Dang, et al.
Pageof 1